Shawn McCarthy joined Regenity in January 2020. Shawn is an accomplished global healthcare executive with nearly 30 years of experience in medical devices, most recently serving as General Manager of Structural Heart Valves at Boston Scientific, where he was responsible for developing and launching a range of innovative and clinically significant products and acquiring key technologies.
Prior to Boston Scientific, Shawn was President and CEO at Tryton Medical, a privately held venture-backed startup which earned the first global approval for a dedicated coronary bifurcation stent. He also held a range of management roles with increasing responsibility at Cordis, a Johnson & Johnson company, culminating as Worldwide Vice President of Marketing for Cardiology, Endovascular, and Neurovascular. Subsequent to Johnson & Johnson, McCarthy was Senior Vice President and General Manager of both the Vascular and Oncology Surgery business units at AngioDynamics.
Shawn holds a Master of Business Administration and a Bachelor of Arts degree in Economics from Syracuse University.
At Regenity, we create material transformations. I’m proud of our team’s commitment to transforming lives as a global leader in regenerative medicine.
Looking for a career with purpose? Join our team and work with us to develop life-changing products that help patients heal. Visit our careers page to learn more about what sets Regenity apart.